Indinavir, Zidovudine, Lamivudine: 3-Year Follow-up
- Mark S. Dworkin, MD, MPHTM; and
- Pei-Chun T. Wan, MS
- Centers for Disease Control and Prevention; Atlanta, GA 30333 (Dworkin, Wan)
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about …
RSS Feeds









